Stock LIFE LIFECARE
Add to a list
To use this feature you must be a member
Log inSign up

Financials Lifecare

Equities

LIFE

NO0010591191

Biotechnology & Medical Research

Market Closed - Oslo Bors
Other stock markets
 08:15:00 10/05/2024 pm IST 		5-day change 1st Jan Change
2.645 NOK -2.04% Intraday chart for Lifecare -13.56% -40.70%
07/05 Entero Healthcare Solutions to Acquire Majority Stake in Avenir Lifecare Pharma MT
26/04 Lifecare to Take Majority Stake in Medical Technology Company RemovAid MT

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 601.5 356.7 - -
Enterprise Value (EV) 1 601.5 283.8 356.7 356.7
P/E ratio - - - -
Yield - - - -
Capitalization / Revenue 52 x 41 x 5.06 x 1.35 x
EV / Revenue 52 x 32.6 x 5.06 x 1.35 x
EV / EBITDA -18.2 x -4.55 x -6.5 x 9.34 x
EV / FCF -15.4 x -4.51 x -3.37 x -
FCF Yield -6.47% -22.2% -29.7% -
Price to Book - - - -
Nbr of stocks (in thousands) 1,34,866 1,34,866 - -
Reference price 2 4.460 2.645 2.645 2.645
Announcement Date 27/02/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 11.56 8.7 70.5 264.2
EBITDA 1 -33.01 -62.4 -54.9 38.2
EBIT 1 -35.88 -66.6 -60.3 24.9
Operating Margin -310.4% -765.52% -85.53% 9.42%
Earnings before Tax (EBT) - - - -
Net income - - - -
Net margin - - - -
EPS - - - -
Free Cash Flow 1 -38.94 -63 -106 -
FCF margin -336.82% -724.14% -150.35% -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 27/02/24 - - -
1NOK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - 2.568 5.152
EBITDA 1 - -6.055 -14.54
EBIT 1 - -6.658 -15.32
Operating Margin - -259.32% -297.27%
Earnings before Tax (EBT) - - -
Net income -8.165 -7.029 -
Net margin - -273.75% -
EPS -0.0690 - -
Dividend per Share - - -
Announcement Date 23/08/23 14/11/23 27/02/24
1NOK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 72.9 - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -38.9 -63 -106 -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex 1 0.82 15 40 -
Capex / Sales 7.13% 172.41% 56.74% -
Announcement Date 27/02/24 - - -
1NOK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
LIFECARE Stock Lifecare
-40.70% 32.89M
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. LIFE Stock
  4. Financials Lifecare
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW